BSE filing, NSE: SYMBIOX. Summary written from the filing by ALFA Finder's alert engine.
Symbiox Investment & Trading Co. Ltd: key numbers
- Share price
- ₹1.61
- Market cap
- ₹5.04 Cr
- Revenue (annual)
- ₹1.60 Cr
- Net profit (annual)
- ₹0.15 Cr
- P/E (TTM)
- 34.3×Sector 21.2×
- Promoter holding
- 3.33%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Symbiox Investment & Trading Co. Ltd
All →Symbiox Investment & Trading Co Board Meeting Date
SYMBIOX INVESTMENT & TRADING CO. LTD intimated a board meeting on 13 Nov 2026 to consider unaudited standalone quarterly results for September 2026. Trading window closed from 01 Oct to 13 Nov 2026.
Symbiox Investment & Trading Co Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) as mandated by SEBI regulations. This filing contains no material business events or corporate transactions.
Symbiox Investment & Trading Co Annual General Meeting
Symbiox Investment & Trading Company Ltd held its 47th Annual General Meeting on September 28, 2026. Shareholders adopted audited financial statements and re-appointed Mrs. Sunita Show as Director.
Symbiox Investment & Trading Company Annual Report
Symbiox Investment & Trading Company Ltd submitted its 47th Annual Report for the financial year 2025-26. The report includes the notice for the upcoming Annual General Meeting.
Symbiox Investment & Trading Co Other Announcement
Symbiox Investment & Trading Company Ltd has issued a circular to shareholders providing the web-link and access path for its FY 2025-26 Annual Report.
Symbiox Investment & Trading Co Annual General Meeting
Symbiox Investment & Trading Company Ltd will hold its 47th Annual General Meeting on September 28, 2026. The agenda includes adopting FY26 financial statements and director re-appointment.
Other price movement clarification announcements
All →Sigachi Industries Price Movement Clarification
Sigachi Industries responded to NSE's query on a significant volume spurt, stating it has disclosed all material information. The company attributes the movement to market conditions.
Narayana Hrudayalaya Price Movement Clarification
Narayana Hrudayalaya responded to a Bloomberg report that Aster DM is in talks to acquire northern India hospitals. The company said it does not comment on speculation and has no disclosable event.
GHCL Textiles Price Movement Clarification
GHCL Textiles confirmed no specific reason for the volume spike, attributing it to market-driven activity. No pending Reg 30 disclosure exists.
Centenial Surgical Suture Price Movement Clarification
Centenial Surgical Suture reports an abnormal share price rise to BSE, alleging possible market manipulation. The company requests SEBI and BSE to investigate and take penal action.
Hubtown Price Movement Clarification
Hubtown Ltd responded to NSE's spurt-in-volume query, stating no price-sensitive information was withheld and management has no connection to the volume increase. No new information or event is disclosed.
Bharat Parenterals Price Movement Clarification
Bharat Parenterals replied to BSE's price movement query, stating it holds no undisclosed material information. The company attributes the recent price movement to market forces.